The prevalence and predictors of herb-drug interactions among Iranian cancer patients during chemotherapy courses

被引：0
作者：
Maliheh Sadat Bazrafshani
Abbas Pardakhty
Behjat Kalantari Khandani
Haleh Tajadini
Sadra Ghazanfari Pour
Sara Hashemi
Shiva Amiri
Soheil Mehmandoost
Amin Beigzadeh
Samaneh Abbaszadeh
Hamid Sharifi
机构：
[1] HIV/STI Surveillance Research Center,Pharmaceutics Research Center
[2] and WHO Collaborating Center for HIV Surveillance,Department of Internal Medicine, Hematology and Oncology Division
[3] Institute for Futures Studies in Health,Physiology Research Center, Institute of Neuropharmacology
[4] Kerman University of Medical Sciences,Student Research Committee
[5] Neuropharmacology Institute,Departement of Medical Chemistry, Faculty of Pharmacy
[6] Kerman University of Medical Sciences,Department of Toxicology and Pharmacology, Faculty of Pharmacy
[7] Kerman University of Medical Sciences,undefined
[8] Kerman University of Medical Sciences,undefined
[9] Kerman University of Medical Sciences,undefined
[10] Kerman University of Medical Sciences,undefined
[11] Kerman University of Medical Sciences,undefined
[12] Sirjan School of Medical Sciences,undefined
来源：
BMC Complementary Medicine and Therapies | / 23卷
关键词：
Cancer; Chemotherapy; Herbal medicine; Food/Herbal drug interactions;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 148 条
[21]  
Loong L(2018)Why people use herbal medicine: insights from a focus-group study in Germany BMC Complement Altern Med 18 1-152
[22]  
Greener M(2012)An overview of the evidence and mechanisms of herb–drug interactions Front Pharmacol 3 69-912
[23]  
Asiimwe JB(2019)Herb-drug interactions and hepatotoxicity Curr Drug Metab 20 275-310
[24]  
Nagendrappa PB(2013)Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs Br J Cancer 108 1071-2685
[25]  
Atukunda EC(2009)Identification and exploration of herb-drug combinations used by cancer patients Integr Cancer Ther 8 29-137
[26]  
Kamatenesi MM(2006)Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes Life Sci 78 856-54
[27]  
Nambozi G(2019)Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the US Food and Drug Administration Adverse Event Reporting System (FAERS) Expert Opin Drug Saf 18 145-53
[28]  
Tolo CU(2009)In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients Phytother Res 23 906-4
[29]  
Ong’udi M(2017)Potential drug interactions with dietary and herbal supplements during hospitalization Intern Emerg Med 12 301-e717
[30]  
Mutai P(2020)Potential herb–drug interactions in community-dwelling older adults in China: the Shanghai Aging Study Aging Clin Exp Res 32 2677-116
12345678910